At Cellistic, iPSC scale-up isn’t a flavor-of-the-day. It’s a first language. It’s a promise waiting to be kept. It’s how the next generation of allogeneic cell therapy innovators will improve patients’ lives everywhere. And it’s all driven here by a team with deep, diverse expertise in the business and science of cell therapy.
Gustavo Mahler, PhD
Chief Executive Officer
Stefan Braam, PhD
Chief Technical Officer
Andy Holt
Chief Commercial Officer
Elena Matsa, PhD
Senior Vice President, Cell Therapy Research
Suzanne Snellenberg, PhD
Director of Genome Engineering
Eva D’amico, PhD
Senior Scientist